Literature DB >> 3922845

Long-term follow-up of patients with Crohn's disease. Relationship between the clinical pattern and prognosis.

R G Farmer, G Whelan, V W Fazio.   

Abstract

In a study of 615 new patients with Crohn's disease consecutively diagnosed at the Cleveland Clinic between 1966 and 1969, 592 patients were observed (mean greater than 13 yr, minimum 7 yr), giving a follow-up rate of 96.3%. The original hypothesis was that initial anatomic involvement (the clinical pattern) bears directly on clinical course and prognosis. Disease sites were as follows: 246 ileocolic, 165 small intestine, and 181 colon/anorectal. Among patients with ileocolic disease, 225 (91.5%) had surgery. For the small intestine pattern, the operative incidence was 65.5%; for the colon/anorectal pattern, it was 58%. Operations were for specific reasons: internal fistula with abscess or intestinal obstruction for ileocolic pattern; intestinal obstruction for small intestine pattern; and severe perianal disease or toxic megacolon for colon/anorectal pattern. Complications among nonoperated patients included perianal fistulas and extraintestinal manifestations. No statistical correlation existed between type and duration of medical treatment and prognosis. Seventy-five deaths occurred (12.8%), 36 of which related directly to Crohn's disease. Even after many years, symptoms continued and quality of life tended to be suboptimal among operated patients. For nonoperated patients, the most favorable quality of life was experienced by those with segmental involvement of the colon or ileum. Poor prognosis correlated with ileocolic disease and presence of sepsis because of an internal fistula.

Entities:  

Mesh:

Year:  1985        PMID: 3922845     DOI: 10.1016/0016-5085(85)90006-x

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  82 in total

1.  Marker antibody expression stratifies Crohn's disease into immunologically homogeneous subgroups with distinct clinical characteristics.

Authors:  E A Vasiliauskas; L Y Kam; L C Karp; J Gaiennie; H Yang; S R Targan
Journal:  Gut       Date:  2000-10       Impact factor: 23.059

2.  Balancing the risks and benefits of infliximab in the treatment of inflammatory bowel disease.

Authors:  W J Sandborn; E V Loftus
Journal:  Gut       Date:  2004-06       Impact factor: 23.059

3.  Risk factors for surgery and postoperative recurrence in Crohn's disease.

Authors:  O Bernell; A Lapidus; G Hellers
Journal:  Ann Surg       Date:  2000-01       Impact factor: 12.969

Review 4.  Ampullary stenosis with biliary obstruction in duodenal Crohn's disease: a case report and review of the literature.

Authors:  Kenny Yung; Jaime Oviedo; Francis A Farraye; James M Becker; Charles W Andrews; David Lichtenstein
Journal:  Dig Dis Sci       Date:  2005-06       Impact factor: 3.199

Review 5.  Wound healing and fibrosis in intestinal disease.

Authors:  F Rieder; J Brenmoehl; S Leeb; J Schölmerich; G Rogler
Journal:  Gut       Date:  2007-01       Impact factor: 23.059

6.  Wireless capsule endoscopy versus ileocolonoscopy for the diagnosis of postoperative recurrence of Crohn's disease: a prospective study.

Authors:  A Bourreille; M Jarry; P N D'Halluin; E Ben-Soussan; V Maunoury; P Bulois; S Sacher-Huvelin; K Vahedy; E Lerebours; D Heresbach; J F Bretagne; J F Colombel; J P Galmiche
Journal:  Gut       Date:  2006-01-09       Impact factor: 23.059

7.  Indomethacin and retinoic acid modify mouse intestinal inflammation and fibrosis: a role for SPARC.

Authors:  Borut Klopcic; Amber Appelbee; Warren Raye; Frances Lloyd; James C I Jooste; Cynthia Heather Forrest; Ian Craig Lawrance
Journal:  Dig Dis Sci       Date:  2008-06       Impact factor: 3.199

Review 8.  Restorative procedures in colonic crohn disease.

Authors:  Sean T Martin; Jon D Vogel
Journal:  Clin Colon Rectal Surg       Date:  2013-06

9.  Postoperative outcome of Crohn's disease in 30 children.

Authors:  M Besnard; O Jaby; J F Mougenot; L Ferkdadji; A Debrun; C Faure; P Delagausie; M Peuchmaur; Y Aigrain; J Navarro; J P Cézard
Journal:  Gut       Date:  1998-11       Impact factor: 23.059

Review 10.  Are we giving azathioprine too late? The case for early immunomodulation in inflammatory bowel disease.

Authors:  María Josefina Etchevers; Montserrat Aceituno; Miquel Sans
Journal:  World J Gastroenterol       Date:  2008-09-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.